leisure time -WSS

leisure time

author：explore 2025-09-30 02:29:52 - browse：3

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout LOUD podcast: ESMO highlights & Roivant's big deal

hotspot

WSS

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Insmed lung disease drug hits target in key Phase 3 trial

Heat waves linked to early deliveries, preterm births in new study

After Sarepta trial failure, Duchenne families brace for more debate

iTeos Therapeutics debuts first data on TIGIT

Insmed lung disease drug hits target in key Phase 3 trial

hotspot

leisure time

entertainment

Alkermes shareholders re

Do more moles mean more problems? Not so, says new study

Moonlake's readout produced a cash windfall. Risks remain

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Moonlake's readout produced a cash windfall. Risks remain

Latest bird flu infection made farmworker sicker than earlier cases

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare proceeds with plan to claw back hospital funds

Wildfire smoke exposes gaps in outdoor worker protections

Coloradans with cystic fibrosis could lose access to Trikafta

hotspot

Bill would allow buprenorphine prescription for addiction via telehealth

Kidney transplant patients stopped immunosuppressants in trial

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Prosthetic arm enables patients to feel the objects they grip

How neuroscience research could help beat back brain cancer

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Wikipedia

hotspot

entertainment

entertainment